gliclazide and Malignant Melanoma

gliclazide has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Celentano, A; Cirillo, N; Lo Muzio, L; McCullough, MJ; Morgan, DJ; Pedicillo, MC; Prime, SS	1

Other Studies

1 other study(ies) available for gliclazide and Malignant Melanoma

Article	Year
Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2. British journal of cancer, 2017, Sep-26, Volume: 117, Issue:7 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenocorticotropic Hormone; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Proliferation; Cortisone; Culture Media, Conditioned; Down-Regulation; Epithelial Cells; Gene Silencing; Glycyrrhetinic Acid; HT29 Cells; Humans; Hydrocortisone; Keratinocytes; MCF-7 Cells; Melanoma; Paracrine Communication; Receptors, Glucocorticoid; Skin Neoplasms	2017

Article

Year

Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.

British journal of cancer, 2017, Sep-26, Volume: 117, Issue:7

Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenocorticotropic Hormone; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Proliferation; Cortisone; Culture Media, Conditioned; Down-Regulation; Epithelial Cells; Gene Silencing; Glycyrrhetinic Acid; HT29 Cells; Humans; Hydrocortisone; Keratinocytes; MCF-7 Cells; Melanoma; Paracrine Communication; Receptors, Glucocorticoid; Skin Neoplasms

2017